IMPROVING ONCOLOGY INVESTIGATE WITH INTEGRATED KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

while in the rapidly evolving subject of oncology study, correct and economical mutation screening is essential for developing targeted therapies. The KRAS companies Platform performs a pivotal position During this landscape by offering comprehensive remedies for KRAS mutation profiling and analysis. KRAS mutations, found in close to 95% of RAS-sim